EFTR - eFFECTOR Therapeutics GAAP EPS of -$2.16 beats by $0.01
2024-05-10 06:33:54 ET
More on eFFECTOR Therapeutics
- eFFECTOR stock slides on decision to discontinue development of tomivosertib for lung cancer treatment
- Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics
- Historical earnings data for eFFECTOR Therapeutics
- Financial information for eFFECTOR Therapeutics